• Skip to primary navigation
  • Skip to main content

Skin Care & Laser Dermatology Clinic | Dr. Derek Jones : Los Angeles, Beverly Hills

Skin Care and Laser Dermatology Clinic, led by Dr. Derek Jones, offers a wide array of services in general and cosmetic dermatology. Contact our dermatologists in Los Angeles and book a consultation today!

  • 310.246.0495
  • Book Online
  • About Us
    • Our Physicians
      • Dr. Derek Jones
        • Dr. Derek Jones' CV
        • Publications, Posters & Presentations
        • Dr. Jones In the Media
        • Research
      • Dr. Nassian Wesley
        • Dr. Wesley's CV
        • Dr. Wesley in the Media
        • Dr. Naissan Wesley – Dermatology Research in Beverly Hills
      • Dr. Ardalan Minokadeh
        • Dr. Minokadeh's CV
      • Dr. Cory Kosche
        • Dr. Kosche's CV
    • Our Esthetician
    • Our Blog
    • Testimonials
  • Surgical & Medical Dermatology
    • All Dermatology Services
    • Mohs Micrographic Surgery
    • Skin Cancer
    • Melanoma
  • Aesthetic Dermatology
        • Botox and Similar Products
          • BOTOX®
          • Jeuveau™
          • Daxxify™
          • XEOMIN®
          • DYSPORT®
        • Fillers
          • Collagen & Dermal Fillers
            • Juvéderm Voluma™ XC
            • Juvéderm® Ultra
            • Juvéderm® Vollure
            • Juvéderm® Volbella® XC
            • Juvéderm® Volux™
            • Restylane®
            • Evolysse®
            • RHA®
            • Belotero Balance®
            • Radiesse®
            • SCULPTRA®
        • Lasers
          • Laser Skin Resurfacing
            • Intense Pulsed Light (IPL)
            • AVAVA™
            • VBEAM & Excel V
            • Fraxel® Dual
            • UltraPulse™ C02
            • Clear + Brilliant
          • Laser Hair Removal
          • Microneedling and PRP
        • Other Procedures
          • Coolsculpting® Fat Reduction
          • Kybella®
        • Aesthetic Services
          • Medical Esthetician Services
          • Chemical Peels
          • HydraFacials
          • Facials
          • Microdermabrasion
          • Meet Lola Ceballos
  • Interests
        • Anti-Aging
          • Midface Volume
          • Hollow Temples
          • Frown Lines
          • Smile Lines
          • Deep Wrinkles
          • Fine Line & Wrinkles
          • Crows Feet
          • Jawline Fillers
          • Chin Fillers
          • Lip Fillers
          • Lip Lines (Smoker Lines)
          • Facial Veins
          • Hair Loss Treatment
          • Hair Removal
          • Hand Rejuvenation
          • Neck Bands
          • Skin Laxity & Volume Loss
          • Skin Texture
          • Spider & Varicose Veins
          • Sun Damage Treatment
        • General Conditions
          • Acne
        • Body
          • Abdomen & Flank Contouring
  • Galleries
    • Photo Gallery
    • Video Gallery
  • Contact
    • Patient Resources
    • Patient Forms
    • Insurance Information
    • Pay Bill
LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
TW9udHNlcnJhdDpyZWd1bGFy
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

Blog

BOOK ONLINE

A Third Cosmetic Use for BOTOX® Gets Approval

As a dermatologist instrumental in investigating the benefits and safety of addressing crow’s feet with BOTOX® treatments, Los Angeles-based physician Dr. Derek Jones has long used the injectable cosmetic for a range of applications, some officially approved by the U.S. Food and Drug Administration and some considered off-label. Toward the end of 2017, the FDA gave BOTOX® Cosmetic a new stamp of approval, bringing the total federally recognized cosmetic uses up to three.

Already enjoying FDA approvals for frown lines and crow’s feet, BOTOX® now has the government’s nod to be marketed as a treatment for horizontal forehead lines—a change that makes the most popular cosmetic treatment in the country now the most versatile such treatment as well. No other neurotoxin (the word for botulinum toxin-based injectables, of which BOTOX® is just one example) is indicated for three areas on the face. In the United States, it is the sole neurotoxin approved by the FDA for aesthetic applications beyond frown lines—technically known as glabellar lines.

Clinical trials revealed that BOTOX® Cosmetic was considered more effective than a placebo at smoothing out frown lines, assessed at 30 days after the treatment by both an investigator and the test subjects themselves. In fact, subjects who received injections of the actual cosmetic and found it effective once they reached their primary endpoint numbered 61 percent in the first trial and 46 percent in the second. Subjects who received the placebo and found it to be effective at the same endpoint numbered zero in the first trial and 1 percent in the second.

Three treatment cycles yielded overall similar response rates.

What does this mean for patients who choose Skin Care and Laser Physicians of Beverly Hills? Since the physician-only team is already experienced in using the injectable to treat forehead lines—and more—available applications will remain the same, but women and men alike can find satisfaction in their choice of the reliable, effective, and popular BOTOX®.

For more information or to set up a consultation, call 310-246-0495 or visit the Contact Us page.

Previous
Next

9201 W. Sunset Blvd. Suite 602
Los Angeles, CA 90069 US
310.246.0495

SERVICES

Medical Dermatology
Surgical Dermatology
Aesthetic Dermatology

PATIENTS

About Us
Blog
Patient Resources
Contact

FOLLOW US

© 2026 Skin Care & Laser Physicians of Beverly Hills. All Rights Reserved. | Sitemap | Privacy Policy | Notice of Privacy Practices | Terms of Service

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © 2026 · Dynamik-Gen on Genesis Framework · WordPress · Log in